![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/74 | |
A61K 38/16 | |||
A61K 38/00 | |||
A61K 9/00 | |||
A61K 9/06 | |||
A61K 47/38 | |||
A61K 38/17 |
(11) | Number of the document | 2819682 |
(13) | Kind of document | T |
(96) | European patent application number | 13755720.3 |
Date of filing the European patent application | 2013-03-01 | |
(97) | Date of publication of the European application | 2015-01-07 |
(45) | Date of publication and mention of the grant of the patent | 2017-05-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/028727 |
Date | 2013-03-01 |
(87) | Number | WO 2013/131040 |
Date | 2013-09-06 |
(30) | Number | Date | Country code |
201261605528 P | 2012-03-01 | US |
(72) |
GHATNEKAR, Gautam, US
|
(73) |
Firststring Research, Inc.,
300 West Coleman Blvd. Suite 203, Mount Pleasant, SC 29464,
US
|
(54) | TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES |
TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES |